"/> Novus Biologicals™ Antigène protéique recombinant… | B-LABO France

Novus Biologicals™ Antigène protéique recombinant CEACAM19

Réf. : BL-RE-044533Réf. fabricant : 18254091
242,97 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
56971
Méthode de purification
>80% by SDS-PAGE and Coomassie blue staining
Nom usuel
CEACAM-19 Recombinant Protein Antigen
Contenu et stockage
Store at −20°C. Avoid freeze-thaw cycles.
Formule
PBS and 1M Urea, pH 7.4.
Marque
Novus Biologicals

A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human CEACAM19.

Points forts

Source

E.coli

Amino Acid Sequence

PQKNQDLLLSVQGVPDTFQDFNWYLGEETYGGTRLFTYIPGIQRPQRDGSAMGQRDIVGFPNGSMLLRRAQPTDSGTYQVAITINSEWTMKAKTEVQVAEKNKELPSTHLPT The CEACAM19 Recombinant Protein Antigen is derived from E. coli. The CEACAM19 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-044533
Réf. fabricant18254091
Gene ID (Entrez)56971
Méthode de purification>80% by SDS-PAGE and Coomassie blue staining
Nom usuelCEACAM-19 Recombinant Protein Antigen
Contenu et stockageStore at −20°C. Avoid freeze-thaw cycles.
FormulePBS and 1M Urea, pH 7.4.
À utiliser avec (application)Blocking/Neutralizing, Control
Alias de gènecarcinoembryonic antigen-related cell adhesion molecule 19
Symbole de gène(s)CEACAM19
Type d’étiquetteUnlabeled
Type de produitRecombinant Protein Antigen
Quantité100μL
État réglementaireRUO
Catégorie de rechercheApoptosis, Cancer
SourceE.Coli
Réactivité spécifiqueThis recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-51806. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml
Une question, une configuration particulière ?
Contactez-nous pour un devis.